Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients
Author(s) -
Jonathan Lambourne,
Dan Agranoff,
Raoul Herbrecht,
Peter F. Troke,
Aby Buchbinder,
Fenella Willis,
Valérie LetscherBru,
Samir Agrawal,
Sarah Doffman,
Elizabeth M. Johnson,
P. Lewis White,
Rosemary A. Barnes,
George E. Griffin,
Jodi A. Lindsay,
Thomas S. Harrison
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/644619
Subject(s) - mannan binding lectin , aspergillosis , immunology , medicine , lectin , aspergillus , biology , microbiology and biotechnology
Invasive aspergillosis is a devastating infection with attributable mortality of 40% despite antifungal therapy. In animal models of aspergillosis, deficiency of mannose-binding lectin (MBL), a pattern recognition receptor that activates complement, is a susceptibility factor. MBL deficiency occurs in 20%-30% of the population. We hypothesized that MBL deficiency may be a susceptibility factor for invasive aspergillosis in humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom